Godsey & Gibb Inc. Boosts Stock Holdings in Agilent Technologies, Inc. $A

Godsey & Gibb Inc. boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 19.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 166,664 shares of the medical research company’s stock after acquiring an additional 27,520 shares during the period. Godsey & Gibb Inc. owned 0.06% of Agilent Technologies worth $19,668,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the 1st quarter worth $30,000. Opal Wealth Advisors LLC bought a new stake in Agilent Technologies during the 1st quarter valued at about $31,000. Ransom Advisory Ltd bought a new stake in Agilent Technologies during the 1st quarter valued at about $32,000. Central Pacific Bank Trust Division bought a new stake in Agilent Technologies during the 2nd quarter valued at about $33,000. Finally, Zions Bancorporation National Association UT bought a new stake in Agilent Technologies during the 1st quarter valued at about $38,000.

Wall Street Analysts Forecast Growth

A has been the subject of a number of research analyst reports. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday. Evercore ISI cut their price objective on shares of Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating on the stock in a research report on Thursday, August 28th. Wells Fargo & Company lifted their price objective on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a research report on Saturday, September 27th. Finally, Barclays lifted their price objective on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 2nd. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $142.17.

Agilent Technologies Stock Performance

A opened at $141.64 on Tuesday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The firm has a fifty day moving average price of $123.24 and a 200 day moving average price of $116.49. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The stock has a market cap of $40.15 billion, a P/E ratio of 33.25, a P/E/G ratio of 4.62 and a beta of 1.26.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the previous year, the business posted $1.32 EPS. The business’s revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.